home / stock / ebs / ebs news


EBS News and Press, Emergent Biosolutions Inc. From 08/01/22

Stock Information

Company Name: Emergent Biosolutions Inc.
Stock Symbol: EBS
Market: NYSE
Website: emergentbiosolutions.com

Menu

EBS EBS Quote EBS Short EBS News EBS Articles EBS Message Board
Get EBS Alerts

News, Short Squeeze, Breakout and More Instantly...

EBS - Emergent BioSolutions Reports Financial Results for Second Quarter 2022

Reports strong core products segment performance offset by impact of continuing post-COVID transition and re-baselining of CDMO services segment Resumes financial guidance; provides update to full year 2022 outlook GAITHERSBURG, Md., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Emergent Bi...

EBS - Monkeypox Stocks GOVX, VRAX, SIGA Rocket on Vaccine Shortage Fears

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Monkeypox stocks are rallying amid worries about a shortage of vaccines for the illness in the U.S. Additionally, in recent days, New York state , New York City and San Francisco have issued emergency orders related to m...

EBS - Notable earnings after Monday's close

AFL , AMKR , AMRC , ANET , ATVI , AWR , AXNX , BCC , BRX , BSM , CACC , CAR , CF , CLAR , CRK , CSR , CSWC , CVI , DAC , DVA , DVN , DZSI , EBS , EHC , ENSG , EPR , EQC , EVER ,...

EBS - SIGA Technologies drops 32% after FDA monkeypox update questions company antiviral

SIGA Technologies ( NASDAQ: SIGA ) has dropped 32% in late Friday afternoon trading after a U.S. FDA monkeypox update stated that the company smallpox antiviral Tpoxx (tecovirimat) has not demonstrated efficacy or safety in human studies. Tpoxx is being made availa...

EBS - Why Emergent BioSolutions Stock Is Jumping This Week

Shares of Emergent BioSolutions (NYSE: EBS) were jumping 14.6% this week as of the market close on Thursday, according to data provided by S&P Global Market Intelligence . The stock's momentum began after the World Health Organization (WHO) director-general declared the glob...

EBS - Tonix announces partnership to study monkeypox vaccine in 1H 2023

Clinical-stage biotech Tonix Pharmaceuticals ( NASDAQ: TNXP ) announced a partnership with the Kenya Medical Research Institute on Thursday to design and conduct a Phase 1 clinical trial in the African country for TNX-801, a vaccine targeted at monkeypox and smallpox. Chie...

EBS - Feds may need $7B to adequately respond to monkeypox outbreak - WaPo

The Biden administration may require as much as $7B in order to deal with the current monkeypox outbreak in the country, according to a memo obtained by The Washington Post . The money would be used for monkeypox vaccines, treatments, and testing. It would also allow HHS t...

EBS - Hot Penny Stocks To Watch As Monkeypox Gets WHO GHE Designation

If you thought monkeypox was a fad, you might want to reconsider. While it isn’t as significant (so far) as other viruses like coronavirus, it is spreading globally. Over the weekend, the World Health Organization inadvertently gave a boost to attention to certain penny stocks , ...

EBS - Monkeypox plays take off as WHO sounds alarm over current outbreak

The companies offering solutions to monkeypox are on the rise in the pre-market after The World Health Organization classified the current outbreak of the rare viral disease as a public health emergency of international concern (PHEIC) on Saturday. Notable gainers include monkey...

EBS - Bavarian Nordic monkeypox vaccine Imvanex gets approval in EU

The European Commission (EC) approved the expanded use of Bavarian Nordic's ( OTCPK:BVNKF ) ( OTCPK:BVNRY ) smallpox vaccine Imvanex for use in preventing monkeypox and disease caused by vaccinia virus. The Denmark-based company's stock rose +4.73% to DKK349.8 o...

Previous 10 Next 10